A17V (p.Ala17Val) variant of HMGCS2 (P54868)

A17V (p.Ala17Val) in HMGCS2 (P54868) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of 3-hydroxy-3-methylglutaryl-CoA synthase deficiency. The available variant effect predictions contribute to a CATVariant prioritization score of 0.14 / 1. The record also includes population frequency data and structural context.

A17V (p.Ala17Val) variant details